Ensurge Micropower ASA

01/19/2022 | Press release | Distributed by Public on 01/19/2022 01:16

Ensurge enters the fast-growing digital health market through a major customer agreement

Tid19.01.2022, 07:10:00
MeldingsID551575
UtstederIDENSU
MarkedOslo Børs
Andre språk
Korrigerte versjoner
KategoriINNSIDEINFORMASJON
  • Informasjonspliktige opplysninger
    Informasjonspliktige opplysninger i henhold til lov, forskrift eller børsens egne regler for markedet verdipapiret er notert på.
  • Lagringspliktig melding
    Med lagringspliktige meldinger menes meldinger som skal oppbevares i offisiell lagringsmekanisme (OAM) etter verdipapirhandelloven § 5-12 og/eller børsens egne regler.
Vedlegg
Del melding

Ensurge enters the fast-growing digital health market through a major customer agreement

Oslo, 19 January 2022

Ensurge Micropower ASA (OSE: ENSU, OTCQB: ENMPY) today announced the signing
of a customer agreement with a leader and innovator in the digital health
market. Under the terms of the agreement, Ensurge will deliver customized
Ensurge solid-state microbatteries for production starting in the fourth quarter
of 2022. Ensurge is receiving several milestone-based payments for the
customization.

"This win is a significant achievement for Ensurge as it allows us to tap into
the exploding digital health and remote patient monitoring markets," said
Ensurge CEO Kevin Barber. "Ensurge microbatteries bring unique value
propositions to these devices. Flexible form factors, fast charging, ability to
support high current draw and wider temperature range differentiate Ensurge
microbattery in addition to the higher density, charge cycles and safety." He
added: "I am also pleased to note that this agreement includes delivery of
production microbatteries in 2022."

Devices that deliver digital health and remote patient monitoring services have
unique power requirements that align well with Ensurge solid-state
microbatteries. These devices have proliferated over the last few years as the
world has become more health-conscious, offering more business opportunities for
Ensurge. The Covid pandemic has accelerated the adoption of these digital
health monitoring devices, which gives Ensurge a unique position for its well
suited solid-state microbatteries Ensurge is actively engaging with various key
players in this market segment.

Ensurge customer engagement continues to expand beyond hearing aids and
wearables to include medical devices, industrial IoT and earbuds. Ensurge sees
strong customer interest enabling new applications that are possible only with a
combination of solid-state microbattery technology and form factor flexibility
offered by Ensurge. These new applications have the potential to drive the
total market opportunity well beyond existing markets.

About Ensurge

Ensurge is Energizing Innovation(TM) with ultrathin, flexible, and safe energy
storage solutions for wearable devices, connected sensors, and beyond. Ensurge's
innovative solid-state lithium battery (SSLB) technology is uniquely positioned
to enable the production of powerful, lightweight, and cost effective
rechargeable batteries for diverse applications. The company's state-of-the-art
flexible electronics manufacturing facility, located in the heart of Silicon
Valley, combines patented process technology and materials innovation with the
scale of roll-to-roll production methods to bring the advantages of SSLB
technology to established and expanding markets. Ensurge Micropower
ASA ("Ensurge") is a publicly listed company in Norway with corporate
headquarters in Oslo and global headquarters in San Jose, California.


Contact

Ståle Bjørnstad - Investor Relations
E-mail: [email protected]
Phone: +47 99 16 76 72

Kevin Barber - Chief Executive Officer
E-mail: [email protected]


This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.